Hang Lung Group Limited (HK:0010)
:0010
Top Page
Hang Lung Group
(0010)
Select Model
Select Model
Rating:62Neutral
Price Target:
HK$16.00
▲(2.89% Upside)
Action:DowngradedDate:03/31/26
The score is primarily supported by stable-to-good financial fundamentals (strong operating profitability, manageable leverage, and improved recent free cash flow) and a relatively supportive valuation (high dividend yield with a moderate P/E). These positives are tempered by weak technical momentum and management’s guidance that Mainland office weakness is likely to persist for 18–24 months, limiting near-term earnings and payout upside.
Positive Factors
High operating profitability
A very high EBIT margin (~59% in 2025) reflects durable operating leverage in the investment property and mall operations. Sustained margin strength supports cash generation through cycles, funds reinvestment and cushions earnings against cyclical revenue swings in property markets.
Negative Factors
Extended Mainland office headwind
Mainland office weakness is structural near term and meaningful given the region's scale of rental revenue. An 18–24 month drag on office rents will pressure overall leasing income and occupancy, limiting earnings and distributable cash while repositioning and tenant churn are addressed.
Read all positive and negative factors
Positive Factors
Negative Factors
High operating profitability
A very high EBIT margin (~59% in 2025) reflects durable operating leverage in the investment property and mall operations. Sustained margin strength supports cash generation through cycles, funds reinvestment and cushions earnings against cyclical revenue swings in property markets.
Read all positive factors
Hang Lung Group (0010) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$22.86B
Dividend Yield5.62%
Average Volume (3M)799.21K
Price to Earnings (P/E)7.7
Beta (1Y)0.74
Revenue Growth-9.78%
EPS Growth-29.50%
CountryHK
Employees4,004
SectorReal Estate
Sector Strength53
IndustryReal Estate - Diversified
Share Statistics
EPS (TTM)0.49
Shares Outstanding1,361,618,300
10 Day Avg. Volume543,878
30 Day Avg. Volume799,214
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.21
Price to Sales (P/S)1.99
P/FCF Ratio5.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hang Lung Group Business Overview & Revenue Model
Company Description
Hang Lung Group Limited, an investment holding company, operates as a property developer in Hong Kong and Mainland China. The company operates through Property Leasing and Property Sales segments. It develops properties for sale and lease, such as...
How the Company Makes Money
Hang Lung Group makes money primarily through (1) rental income from investment properties and (2) profits from property development activities. For its investment property business, the company earns recurring revenue by leasing retail space (e.g...
Hang Lung Group Earnings Call Summary
Earnings Call Date:Jan 30, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Aug 05, 2026
Earnings Call Sentiment Positive
The call presented a broadly constructive operational and strategic picture: retail recovery (notably strong Q4), record footfall and member growth, improved occupancy and leasing activity, lower gearing and finance cost improvements, progress on ESG, and a new asset-efficient V.3 expansion plan with limited CapEx. However, material near-term challenges remain — notably an extended Mainland office downturn (~8% decline) and select underperforming assets requiring repositioning, plus currency-related revenue drag and cautious luxury demand. On balance, the positives (stabilizing retail momentum, deleveraging, CapEx peak passed and clear strategic initiatives) outweigh the headwinds, but management maintains a cautious tone for 2026.Positive Updates
Retail sales recovery and strong Q4
Retail sales showed a strong recovery with Q3 sales +10% YoY and Q4 sales +18% YoY, contributing to overall retail rental revenue in Mainland China up ~1% YoY. Mainland retail accounts for ~83% of Mainland rental revenue.
Negative Updates
Mainland office weakness and extended headwind
Mainland office rental performance declined ~8% YoY overall (H1 -5%, H2 -12%), driven by supply growth and stronger tenant bargaining power; management expects this headwind to persist for ~18–24 months and noted large tenant restructurings in Shanghai.
Read all updates
Q4-2025 Updates
Positive
Negative
Retail sales recovery and strong Q4
Retail sales showed a strong recovery with Q3 sales +10% YoY and Q4 sales +18% YoY, contributing to overall retail rental revenue in Mainland China up ~1% YoY. Mainland retail accounts for ~83% of Mainland rental revenue.
Read all positive updates
Company Guidance
Management guided that leasing (94% of 2025 revenue) remains the core, with Mainland rental at RMB5,878m (≈68% of total rental), Mainland retail +1% y/y and Mainland office -8% (H1 -5%, H2 -12%) with an expected 18–24 month headwind; Hong Kong was down -2% (improved from -9%). Dividends were unchanged (HLP HKD0.52; HLG HKD0.86) as the Group prioritizes deleveraging (net gearing 32.7% at FY25; 47% of debt RMB‑denominated; 9% of debt maturing within 1 year), with finance costs down 8%, net finance cost up 3% (due to lower capitalisation) and interest cover 3.1x. Management expects disposal cash of HKD1.6bn (HKD264m recognised in 2025; ~HKD1.2bn to be recognised in 2026 — ~HKD700m HK / ~HKD500m Mainland), lower CapEx (2026 ~HKD3.1bn; 2027 ~HKD2.6bn; subsequently down) and only ~RMB1bn attributable V.3 spend to drive asset‑light growth that materially increases façade/GFA (Hangzhou ×3, Shanghai +53%, Wuxi +30%; Plaza 66 LFA +13%; Nanjing Xi Lu retail +80% including +67%/+13%). Operational KPIs are improving (record Q4 footfall; Q3 sales +10%, Q4 +18%; new lettings +15%, renewals +5%; valid members +24%, new members +10%, member sales +7%, penetration +4pts), early project commitment/opening rates are strong (Westlake ~91% committed; Plaza 66 80–90% opening by Q2–Q3; office pre‑leasing ~34%→40%), and management is cautiously optimistic on retail recovery in 2026 while remaining conservative on luxury and focused on reducing leverage before materially increasing payouts.Hang Lung Group Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
64
Positive
Cash Flow
70
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.42B | 11.76B | 11.01B | 10.94B | 10.93B |
| Gross Profit | 6.69B | 6.83B | 7.92B | 7.68B | 7.82B |
| EBITDA | 6.31B | 5.21B | 7.20B | 7.08B | 7.26B |
| Net Income | 1.37B | 1.61B | 2.81B | 2.72B | 2.59B |
Balance Sheet | |||||
| Total Assets | 236.23B | 234.97B | 231.45B | 226.54B | 238.03B |
| Cash, Cash Equivalents and Short-Term Investments | 6.79B | 10.82B | 6.34B | 5.79B | 9.14B |
| Total Debt | 55.37B | 58.06B | 50.97B | 46.25B | 46.22B |
| Total Liabilities | 80.97B | 82.28B | 76.54B | 71.33B | 73.54B |
| Stockholders Equity | 98.88B | 95.78B | 94.36B | 92.82B | 95.84B |
Cash Flow | |||||
| Free Cash Flow | 4.02B | 5.04B | 3.91B | 378.00M | -1.14B |
| Operating Cash Flow | 4.32B | 5.21B | 4.02B | 3.10B | 1.74B |
| Investing Cash Flow | -2.31B | -3.07B | -2.85B | -3.20B | -1.44B |
| Financing Cash Flow | -6.13B | 2.38B | -566.00M | -4.25B | 1.82B |
Hang Lung Group Technical Analysis
Positive
15.55
Price Trends
16.09
Negative
15.82
Negative
14.95
Positive
Market Momentum
-0.15
Negative
52.66
Neutral
69.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0010, the sentiment is Positive. The current price of 15.55 is above the 20-day moving average (MA) of 15.42, below the 50-day MA of 16.09, and above the 200-day MA of 14.95, indicating a neutral trend. The MACD of -0.15 indicates Negative momentum. The RSI at 52.66 is Neutral, neither overbought nor oversold. The STOCH value of 69.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0010.
Hang Lung Group Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$148.82B | 24.10 | 1.76% | 6.20% | -19.91% | -6.92% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$22.86B | 7.71 | 1.39% | 5.62% | -9.78% | -29.50% | |
59 Neutral | HK$12.97B | -6.82 | -3.14% | 5.93% | 1.37% | -157.43% | |
45 Neutral | HK$1.16B | -0.55 | -32.15% | 4.36% | -16.06% | -529.92% | |
40 Underperform | HK$22.52B | -1.70 | -9.54% | ― | -40.92% | -42.67% | |
40 Underperform | HK$887.75M | 0.14 | -154.48% | ― | -57.94% | 45.77% |
* Real Estate Sector Average
HK:0010
Hang Lung Group
16.79
7.21
75.30%
HK:0041
Great Eagle Holdings
17.48
6.04
52.77%
HK:0012
Henderson Land Development Co
30.74
11.92
63.30%
HK:0017
New World Development
8.95
4.47
99.78%
HK:3377
Sino-Ocean Group Holding
0.07
-0.11
-59.22%
HK:0978
China Merchants Land Limited
0.24
0.02
10.80%
Hang Lung Group Corporate Events
Hang Lung Group Sets 2026 AGM to Seek Shareholder Mandates on Buybacks and Issuance
Mar 26, 2026
Hang Lung Group has called its annual general meeting for April 30, 2026, in Hong Kong, where shareholders will review the audited financial statements for the year ended December 31, 2025, vote on a proposed final dividend, re-elect retiring dire...
Hang Lung Group Publishes 2025 Annual Results
Jan 30, 2026
Hang Lung Group Limited has released its 2025 annual results, providing shareholders and the market with a detailed review of operations, consolidated financial statements and accompanying notes, along with other corporate information. The publica...
Hang Lung Group Proposes Final Dividend of HKD 0.65 per Share for 2025
Jan 30, 2026
Hang Lung Group Limited has announced a proposed final ordinary cash dividend of HKD 0.65 per share for the financial year ended 31 December 2025, subject to shareholder approval at its meeting on 30 April 2026. The dividend will be paid in Hong K...
Hang Lung Group Sets January 30 Board Meeting to Approve 2025 Results and Consider Final Dividend
Jan 2, 2026
Hang Lung Group Limited has scheduled a board meeting for January 30, 2026 to review and approve the annual results of the company and its subsidiaries for the financial year ended December 31, 2025. At the same meeting, the board will also consid...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.